December 19, 2024

FDA Approves Mesoblast’s First-Of-Its-Kind Cell Therapy

Learn more

November 14, 2024

PTC Wins FDA Approval For First Brain-Delivered Gene Therapy Kebilidi

Learn more

November 11, 2024

FDA Approves Aucatzyl for Adults with Aggressive Leukemia

Learn more